PATENT CLAIM ANALYSIS

Application Number: 16183638
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "452000"]

Abstract:
Compositions and methods for individualized therapy of pain using a non-steroidal anti-inflammatory drug (NSAID) and an anti-hypertensive without inducing intolerable edema. Said methods comprise basing NSAID/anti-hypertensive dose on each patient's pharmacokinetic response to said NSAID.

Claim (Index 3):
The method of  claim 1 , wherein the composition is in the form of a pill in pill, capsule in capsule,-bilayer tablet or other formulation method with physical separation between celecoxib and lisinopril.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15063000', '10158216', '12426530', '13705552', '12959607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7473633521897424
- 35 USC 102 Novelty (BERT): 0.504966653471442
- Combined Prediction Score: 0.7231236823179124
- Mean Citation Score: 234.952556
- Max Citation Score: 244.79503
- Similarity Product: 169.00841578743814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test